Ario Pharma strengthens scientific advisory board with two key appointments

UK-based biopharmaceutical company Ario Pharma, focused on developing innovative new approaches to treat respiratory disease, has announced the appointment of Professor Peter Barnes and Professor Wisia Wedzicha to its Scientific Advisory Board with immediate effect.

Peter Barnes is Margaret Turner-Warwick Professor of Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College and Honorary Consultant Physician at Royal Brompton Hospital, London. He qualified at Cambridge and Oxford Universities and was appointed to his present post in 1987.

Professor Barnes has published over 1000 peer-review papers on asthma, chronic obstructive pulmonary disease and related topics and has written or edited over 50 books. He is the 7th most highly cited researcher in the world, has been the most highly cited clinical scientist in Europe and the most highly cited respiratory researcher in the world over the last 20 years.